estim
million
children
five
die
mostli
diseas
prevent
vaccin
number
million
die
thu
year
million
live
save
result
develop
new
vaccin
world
health
organ
campaign
vaccin
children
africa
india
lessdevelop
countri
global
vaccin
action
plan
gvap
common
caus
death
among
young
children
acut
respiratori
infect
diarrhea
contamin
sourc
measl
malaria
hiv
malnutrit
death
could
prevent
vaccin
tabl
list
vaccin
administ
children
adult
worldwid
develop
licens
number
case
coverag
avail
world
health
organ
launch
program
decad
action
plan
promot
equit
access
vaccin
throughout
world
one
aim
program
complet
erad
polioviru
howev
program
alreadi
run
troubl
sinc
inhabit
tribal
area
pakistan
certain
group
nigeria
see
vaccin
cia
plot
hinder
complet
elimin
polio
polio
worker
carri
vaccin
program
shot
kill
pakistan
al
qaeda
taliban
result
particip
physician
involv
polio
vaccin
campaign
help
us
militari
physician
collect
inform
osama
bin
laden
household
aid
identifi
al
qaeda
leader
launch
expand
program
immun
less
world
children
age
one
immun
killer
polio
measl
whoop
cough
aim
reach
children
avail
vaccin
current
estim
world
children
age
one
receiv
vaccin
killer
diseas
new
vaccin
hepat
b
administ
see
tabl
howev
onefifth
world
million
immun
diseas
estim
million
children
die
vaccineprevent
diseas
obviou
vaccin
profound
effect
incid
diseas
us
attempt
vaccin
rest
world
mani
diseas
way
smallpox
erad
polio
near
erad
tabl
illustr
effect
vaccin
health
us
much
discuss
recent
whether
need
vaccin
children
mani
infecti
diseas
particular
necess
vaccin
measl
question
troubl
menac
measl
outbreak
occur
variou
part
world
specif
uk
guard
number
known
childhood
diseas
lower
misinform
internet
even
scientif
public
relat
vaccin
autism
patholog
neglect
polio
vaccin
result
epidem
variou
part
middl
east
pakistan
india
year
emerg
vaccin
polio
given
israel
syria
histori
vaccin
develop
histori
public
accept
vaccin
stormi
one
antivaccin
movement
activ
sinc
introduct
smallpox
vaccin
governmentmand
vaccin
us
uk
oppon
vaccin
often
religi
argument
variol
later
vaccin
go
back
eighteenth
centuri
even
jenner
discoveri
cowpox
protect
smallpox
preacher
pronounc
diseas
punish
sin
treat
nation
poll
conduct
show
american
want
get
flu
shot
sinc
worri
side
effect
overvaccin
popul
recent
opposit
stem
report
lancet
link
measl
mump
rubella
vaccin
onset
autism
paper
later
withdrawn
follow
exposur
fabric
data
measl
vaccin
program
uk
lesser
degre
us
sever
damag
discuss
histori
develop
individu
vaccin
present
histori
smallpox
vaccin
present
chap
summar
dr
edward
jenner
practic
physician
berkeley
england
gloucestershir
note
other
milkmaid
appear
immun
smallpox
instead
hand
often
blister
pick
cow
develop
pock
teat
later
shown
caus
cowpox
viru
later
call
vaccinia
jenner
small
laboratori
shadow
berkeley
castl
tortur
chamber
northern
england
inocul
number
children
includ
son
first
cowpox
report
protect
smallpox
peopl
vaccin
worldwid
year
physician
accept
jenner
vaccin
although
resent
jenner
physician
appreci
cure
smallpox
develop
countri
physician
other
may
resent
loss
revenu
treat
smallpox
british
parliament
discuss
jenner
vaccin
upheld
use
claim
inventor
method
despit
success
use
worldwid
continu
opposit
vaccin
stand
initi
success
product
smallpox
vaccin
plagu
problem
least
method
grow
cowpox
viru
amount
larg
enough
suppli
demand
initi
isol
pock
cow
udder
viru
unstabl
long
period
could
ship
long
distanc
could
kept
dri
storag
month
could
toler
heat
exposur
sun
suppli
could
keep
demand
sinc
one
search
cow
cowpox
common
uniqu
method
transfer
viru
armtoarm
transfer
materi
one
individu
format
scab
vaccin
site
anoth
individu
although
hard
believ
girl
recent
vaccin
sent
orphanag
st
petersburg
russia
serv
sourc
smallpox
vaccin
children
week
old
orphanag
continu
practic
one
child
anoth
year
balmi
expedit
goal
bring
vaccin
new
world
american
indian
popul
king
spain
daughter
stricken
smallpox
charl
iv
order
person
physician
de
balmi
deliv
vaccin
inhabit
north
south
america
maintain
vaccin
long
trip
across
atlant
de
balmi
recruit
young
boy
orphanag
spain
age
never
smallpox
trip
de
balmi
sequenti
vaccin
boy
live
chain
continu
ship
reach
venezuela
peopl
thu
vaccin
latin
america
royal
smallpox
expedit
call
recruit
orphan
continu
vaccin
program
philippin
macao
canton
medic
congress
franc
better
method
grow
viru
report
itali
spread
worldwid
present
cowpox
could
grown
larg
quantiti
make
seri
cut
flank
calf
inocul
viru
anim
skin
harvest
materi
pock
day
later
still
crude
way
prepar
vaccin
sinc
often
contamin
hair
bacteria
debri
around
dr
j
clinch
medic
missionari
newfoundland
began
use
jenner
vaccin
end
vaccin
approxim
peopl
probabl
first
vaccin
commun
north
america
compulsori
vaccin
infant
place
bavaria
denmark
norway
bohemia
russia
sweden
british
govern
pass
vaccin
act
smallpox
epidem
made
variol
illeg
suppli
smallpox
vaccin
cowpox
free
charg
vaccin
act
pass
requir
children
receiv
smallpox
vaccin
age
month
later
law
chang
allow
parent
object
vaccin
appeal
known
conscienti
object
law
henc
term
conscienti
objector
us
suprem
court
rule
individu
state
could
impos
mandatori
vaccin
children
despit
perhap
compulsori
vaccin
mani
continu
oppos
vaccin
one
problem
jenner
er
proclaim
immun
would
last
lifetim
fact
immun
effect
laps
year
requir
reinocul
other
still
object
religi
ground
say
interfer
work
lord
quit
high
level
accid
vaccin
directli
taken
pockmark
udder
contamin
virus
bacteria
particular
case
syphili
report
armtoarm
method
sometim
vaccin
quit
activ
antivaccin
campaign
see
illustr
pamphlet
poster
librari
medicin
websit
http
wwwnlmnihgovcopyrighthtml
fig
smallpox
declar
erad
world
intens
struggl
erad
viru
fact
erad
began
spanish
crown
attempt
vaccin
popul
philippin
us
congress
pass
vaccin
act
insur
safe
vaccin
us
public
us
govern
set
program
vaccin
american
indian
also
piecem
attempt
erad
viru
area
world
india
east
indi
smallpox
elimin
us
begin
twentieth
centuri
industri
countri
europ
despit
year
two
million
peopl
die
diseas
unit
nation
launch
campaign
erad
smallpox
world
although
took
longer
expect
last
case
natur
occur
smallpox
somalia
smallpox
easier
erad
virus
follow
reason
acut
infect
neither
chronic
persistentther
nonhuman
reservoir
intermedi
vectoronli
one
speci
viru
pathogenicth
vaccin
rel
stabl
easi
deliv
discuss
elsewher
complet
elimin
viru
world
sinc
stock
retain
research
purpos
us
russia
unfortun
soviet
union
grew
viru
larg
quantiti
biolog
warfar
purpos
vaccin
stop
us
world
advent
global
terror
develop
biolog
weapon
seem
sensibl
reintroduc
vaccin
smallpox
rather
wait
tragic
event
although
report
advers
effect
case
warrant
complet
cessat
consid
fact
vaccin
success
year
smallpox
vaccin
becam
model
develop
vaccin
vaccin
base
similar
one
viru
anoth
produc
crossreact
antibodi
current
vaccin
deriv
clone
viru
origin
grown
calv
produc
cell
cultur
viru
chang
mani
passag
longer
cowpox
novel
poxviru
year
call
vaccinia
origin
jenner
cowpox
lost
rabi
extrem
frighten
danger
infect
folklor
rife
stori
rabid
dog
attack
human
rabi
viru
trigger
foam
mouth
stimul
salivari
gland
produc
copiou
amount
saliva
effici
transmiss
viru
pasteur
roux
develop
rabi
vaccin
viru
attenu
pass
virul
strain
isol
rabid
dog
rabbit
brain
harvest
nerv
tissu
dri
day
result
attenu
viru
vaccin
deliv
patient
form
intramuscular
inject
period
week
anyon
suspect
contact
rabid
anim
develop
vaccin
mire
controversi
sinc
claim
adequ
test
use
young
nineyearold
boy
joseph
meister
emil
roux
young
colleagu
loui
pasteur
studi
md
degre
use
develop
rabi
vaccin
research
topic
pasteur
experiment
scientist
work
vaccin
allow
french
law
treat
patient
joseph
meister
maul
rabid
dog
brought
pasteur
help
pasteur
consult
two
physician
sinc
seem
littl
hope
cure
sinc
rabi
fatal
ask
one
physician
administ
untest
vaccin
use
meister
come
critic
controversi
recent
year
releas
pasteur
notebook
question
ask
whether
vaccin
adequ
test
use
meister
case
doubt
express
whether
boy
bitten
rabid
dog
pasteur
roux
work
vaccin
roux
name
paper
report
treatment
meister
claim
pasteur
lie
paper
state
treat
dog
vaccin
fact
initi
treatment
dog
develop
vaccin
far
enough
along
warrant
use
human
also
specul
roux
might
oppos
use
vaccin
obvious
moral
question
one
possibl
fatal
case
ill
wait
experiment
complet
enigma
face
mani
physician
today
face
new
untest
treatment
cancer
aid
pasteur
work
rabi
vaccin
met
much
skeptic
us
doubt
express
efficaci
vaccin
whether
vaccin
led
death
victim
might
expos
rabid
dog
bitten
healthi
one
vaccin
develop
attenu
rabi
viru
grown
cell
cultur
vaccin
extens
test
four
five
subsequ
inject
result
complet
protect
improv
vaccin
made
grow
rabi
viru
human
embryon
cell
although
hilari
koprowski
team
inocul
new
vaccin
medic
profess
like
idea
use
live
rabi
viru
koprowski
also
clone
rabi
viru
glycoprotein
vaccinia
vaccin
use
control
diseas
wild
anim
inact
rabi
vaccin
call
human
diploid
cell
vaccin
hdcv
licens
europ
us
one
major
advantag
administ
five
inject
rather
inject
older
vaccin
cell
cultur
inact
viru
vaccin
one
choic
tend
sheep
found
injur
anim
sinc
handl
suggest
get
rabi
shot
case
rabid
jackal
bitten
anim
day
modern
vaccin
given
seri
shot
abdomen
precaut
assum
must
pasteur
vaccin
shot
anim
test
neg
number
death
rabi
unit
state
declin
approxim
turn
last
centuri
one
two
per
year
case
due
exposur
wildlif
bat
rest
world
main
sourc
rabi
still
rabid
dog
peopl
die
rabi
year
asia
africa
bitten
suspect
rabid
anim
children
less
year
old
report
panama
canal
open
urgent
need
vaccin
yellow
fever
although
transmit
mosquito
agent
respons
still
unknown
rockefel
institut
new
york
sent
one
scientist
hideyo
noguchi
guayaquil
ecuador
center
epidem
outbreak
investig
possibl
produc
vaccin
ecuador
noguchi
claim
discov
agent
caus
yellow
fever
spirochet
bacterium
leptospira
icteroid
went
develop
vaccin
organ
use
extens
south
america
africa
noguchi
publish
mani
paper
report
success
vaccin
total
case
howev
result
reproduc
filter
retain
agent
use
indic
viral
diseas
statist
faulti
eventu
rockefel
institut
drop
project
materi
also
present
chap
rockefel
institut
launch
anoth
scientif
expedit
time
west
africa
determin
whether
african
yellow
fever
ident
south
american
yellow
fever
aim
character
caus
agent
includ
search
leptospira
icteroid
organ
studi
noguchi
studi
epidemiolog
expedit
led
major
henri
beeuwk
john
hopkinstrain
bacteriologist
retir
armi
adrian
stoke
londonbas
professor
patholog
expert
leptospirosi
noguchi
other
join
june
blood
african
yellow
fever
victim
name
asibi
inject
rhesu
monkey
monkey
becam
ill
symptom
yellow
fever
becam
thu
first
case
anim
model
yellow
fever
short
later
stoke
die
yellow
fever
noguchi
pursu
idea
diseas
caus
leptospira
icteroid
inocul
one
thousand
monkey
blood
yellow
fever
victim
could
find
leptospira
noguchi
also
contract
yellow
fever
die
may
third
investig
perform
autopsi
howev
anim
model
discov
infect
agent
could
remov
laboratori
studi
soon
shown
serum
immun
human
recov
infect
protect
monkey
infect
immun
serum
south
american
patient
protect
african
viru
thu
suggest
one
vaccin
would
offer
protect
global
strain
yellow
fever
call
asibi
french
group
dakar
also
collect
blood
anoth
patient
passag
viru
rhesu
monkey
gave
rise
strain
viru
known
french
strain
viru
could
frozen
work
pursu
laboratori
max
theiler
south
african
work
rockefel
institut
involv
research
leptospira
icteroid
organ
propos
noguchi
caus
agent
yellow
fever
isol
viru
appear
caus
agent
diseas
awar
previou
literatur
rabi
viru
recent
work
grow
herp
viru
brain
mice
theiler
inocul
yellow
fever
viru
mous
brain
found
reproduc
inject
rhesu
monkey
passag
viru
less
pathogen
system
neurotrop
research
extrem
danger
rockefel
institut
announc
case
yellow
fever
eight
laboratori
five
fatal
french
strain
passag
hundr
time
mous
brain
administ
protect
laboratori
field
worker
viru
combin
immun
serum
yellow
feverinfect
lab
worker
prevent
enceph
vaccin
success
use
world
war
ii
meanwhil
french
scientist
develop
differ
vaccin
use
mous
brain
passag
viru
coat
oil
egg
yolk
freezedri
mixtur
suspend
salin
appli
smallpox
vaccin
scarif
sixteen
million
african
vaccin
combin
side
effect
method
origin
develop
theiler
requir
larg
amount
human
serum
sinc
fear
neurotrop
effect
thu
limit
use
cell
cultur
introduc
theiler
passag
viru
chick
embryo
lack
nervou
tissu
time
viru
lost
neurotrop
mice
due
random
mutat
strain
call
side
effect
becam
vaccin
choic
million
peopl
vaccin
south
america
theiler
vaccin
without
side
effect
howev
case
enceph
report
infect
receiv
vaccin
singl
lot
viru
appar
mutat
subcultur
thu
aros
seed
lot
system
origin
cultur
viru
store
use
world
war
ii
saw
huge
demand
vaccin
troop
engag
north
africa
januari
april
million
dose
distribut
one
batch
vaccin
seriou
side
case
jaundic
occur
day
inject
vaccin
contain
small
amount
human
serum
stabil
batch
contamin
hepat
b
thu
decid
switch
serumfre
vaccin
give
vaccin
post
yellow
fever
area
improv
strain
adapt
sole
yellow
fever
vaccin
still
use
today
tremend
effort
went
develop
polio
vaccin
discuss
chap
major
advanc
discoveri
polioviru
mump
viru
could
grow
mous
lung
cell
three
major
research
group
involv
develop
polio
vaccin
jona
salk
albert
sabin
hilari
koprowski
unfortun
bitter
competit
rivalri
three
group
first
vaccin
licens
us
salk
inactiv
polio
vaccin
three
strain
polioviru
inactiv
treatment
formalin
develop
vaccin
great
achiev
jona
salk
becam
nation
hero
second
attenu
vaccin
contain
three
strain
polio
test
licens
two
group
independ
produc
attenu
head
albert
sabin
hilari
koprowski
committe
nation
institut
health
decid
sabin
vaccin
consist
three
mutat
strain
polio
extens
passag
cell
cultur
mice
hilari
koprowski
develop
first
attenu
polioviru
test
group
children
new
york
side
effect
mass
vaccin
trial
koprowski
oral
polio
vaccin
took
place
belgian
congo
poland
croatia
switzerland
approxim
million
individu
vaccin
koprowski
polio
vaccin
million
sabin
vaccin
salk
vaccin
base
three
wild
virul
refer
strain
mahoney
type
polioviru
type
polioviru
saukett
type
polioviru
grown
monkey
kidney
cell
cultur
vero
cell
line
viru
inactiv
formalin
initi
salk
vaccin
vaccin
choic
us
largest
trial
ever
held
children
vaccin
salk
vaccin
effect
type
ii
type
iii
polio
effect
type
larg
industri
facil
built
product
vaccin
export
mani
countri
event
known
cutter
cutter
name
one
pharmaceut
compani
produc
polio
vaccin
dose
salk
vaccin
creat
contain
live
polioviru
instead
inact
one
administr
vaccin
caus
case
polio
case
paralysi
death
diseas
spread
creat
polio
epidem
lead
case
paralyt
polio
anoth
death
call
one
worst
pharmaceut
disast
us
histori
cours
affect
public
attitud
toward
vaccin
order
vaccin
success
public
confid
fact
cutter
incid
led
use
altern
vaccin
sabin
instead
salk
time
mani
health
advoc
believ
sabin
vaccin
better
vaccin
sinc
live
vaccin
provid
herd
immun
viru
shed
spread
throughout
famili
provid
protect
surround
popul
also
assum
immun
inactiv
vaccin
would
long
last
wherea
sabin
vaccin
viru
multipli
gut
would
confer
stronger
immun
respons
sabin
vaccin
replac
salk
vaccin
sinc
given
oral
rather
inject
easier
children
take
parent
administ
howev
low
steadi
number
individu
receiv
vaccin
develop
paralyt
polio
indic
attenu
viru
undergon
mutat
revert
wildtyp
us
cdc
recommend
salk
inactiv
vaccin
campaign
erad
polio
oral
vaccin
prefer
herd
immun
map
area
globe
endem
polio
shown
fig
newer
map
would
includ
syria
paper
appear
lancet
influenti
british
medic
journal
claim
increas
case
autism
children
link
directli
mmr
vaccin
base
studi
head
dr
andrew
wakefield
british
surgeon
specialist
diseas
gastric
tract
particular
claim
found
correl
irrit
bowel
syndrom
autism
vaccin
conclus
base
studi
children
data
present
paper
anecdot
inform
parent
autist
symptom
first
appear
case
said
within
week
mmr
inocul
dr
wakefield
publish
followup
seri
paper
claim
direct
relationship
vaccin
autism
irrit
bowel
syndrom
crohn
diseas
paper
peerreview
mani
appear
lancet
influenti
peerreview
journal
major
argument
present
vaccin
overload
immun
system
virus
three
type
lead
abnorm
immun
respons
inject
measl
viru
young
age
alter
normal
immun
respons
result
aberr
immun
system
lack
natur
exposur
virus
could
lead
irrit
bowel
syndrom
crohn
diseas
autoimmun
diseas
although
also
known
inherit
report
caus
uproar
uk
result
mani
parent
refus
vaccin
children
effect
level
mmr
vaccin
drop
uk
london
within
year
larg
studi
perform
confirm
refut
wakefield
data
one
largest
danish
studi
children
receiv
mmr
children
receiv
correl
mmr
vaccin
autism
detect
studi
quickli
follow
show
similar
result
although
wakefield
group
continu
publish
opposit
conclus
author
first
paper
publish
lancet
retract
authorship
claim
agre
conclus
paper
similar
retract
made
journal
great
deal
damag
done
period
wakefield
stood
result
claim
conspiraci
astound
none
coauthor
origin
paper
realiz
data
wrong
statist
correct
retract
took
long
investig
gener
medic
council
great
britain
found
mani
coauthor
could
identifi
child
discuss
paper
name
agreement
ad
authorship
paper
flimsiest
reason
unfortun
common
occurr
scienc
today
wakefield
case
came
promin
due
investig
report
brian
deer
time
london
deer
publish
first
investig
wakefield
paper
uncov
possibl
research
fraud
uneth
treatment
children
wakefield
conflict
interest
involv
lawsuit
manufactur
mmr
vaccin
deer
publish
summari
work
british
medic
journal
interview
parent
probabl
children
describ
wakefield
paper
found
time
appear
autism
match
report
paper
medic
record
report
correctli
shown
tabl
summari
bmj
paper
present
lancet
paper
case
seri
child
patient
report
propos
new
syndrom
enterocol
regress
autism
associ
mmr
appar
precipit
event
fact
three
nine
children
report
regress
autism
autism
diagnos
one
child
clearli
regress
autism
despit
paper
claim
children
previous
normal
five
document
preexist
development
concern
children
report
experienc
first
behavior
symptom
within
day
mmr
record
document
start
month
vaccin
nine
case
unremark
colon
histopatholog
minim
fluctuat
inflammatori
cell
chang
medic
school
research
review
nonspecif
coliti
parent
eight
children
report
blame
mmr
famili
made
alleg
hospit
exclus
three
give
time
onset
problem
creat
appear
day
tempor
link
patient
recruit
antimmr
campaign
studi
commiss
fund
plan
litig
scientist
difficult
discern
motiv
falsif
data
done
greed
seem
case
compani
show
linkag
mmr
autism
crohn
diseas
even
children
describ
lancet
paper
present
http
briandeercommmrlancetsummaryhtm
compani
creat
england
ireland
us
patent
appli
money
accept
charit
govern
agenc
basi
fals
data
hospit
institut
employ
wakefield
pleas
take
cut
moreov
deer
report
lawyer
plan
sue
vaccin
manufactur
behalf
parent
thought
mmr
caus
children
problem
retain
wakefield
expert
wit
year
earlier
parent
cite
lancet
articl
came
wakefield
clinic
respons
advertis
campaign
led
lawyer
group
call
jab
routin
screen
london
time
andrew
wakefield
former
surgeon
whose
campaign
link
mmr
vaccin
autism
caus
collaps
immun
rate
paid
lawyer
tri
prove
vaccin
unsaf
payment
unearth
sunday
time
part
distribut
legal
aid
fund
doctor
scientist
recruit
support
nowfail
lawsuit
vaccin
manufactur
critic
weekend
voic
amaz
sum
said
creat
clear
conflict
interest
financi
engin
behind
worldwid
alarm
tripl
measl
mump
rubella
shot
accord
figur
releas
freedom
inform
act
wakefield
paid
fee
plu
expens
wakefield
work
lawyer
began
year
publish
notori
report
lancet
medic
journal
februari
propos
link
vaccin
autism
interest
wakefield
paper
cite
retract
paper
time
vaccin
rate
uk
complet
recov
u
annual
morbid
influenza
estim
million
case
hospit
extrapol
number
estim
billion
case
influenza
annual
million
sever
case
death
death
us
age
group
chapter
present
biolog
aspect
influenza
viru
major
antigen
compon
viru
hemagglutinin
protein
neuraminidas
protein
major
surfac
protein
viru
discuss
chap
viru
undergo
random
mutat
high
rate
result
antigen
drift
reassort
even
mix
case
two
virus
differ
origin
result
antigen
shift
make
difficult
predict
makeup
viru
caus
season
outbreak
flu
result
antigen
chang
may
mean
popul
immun
viru
infect
result
pandem
happen
vaccin
predict
year
year
three
type
influenza
vaccin
current
circul
one
contain
inactiv
subunit
viru
given
intramuscularli
intraderm
second
live
vaccin
liav
live
attenu
influenza
vaccin
given
intranas
vaccin
three
speci
influenza
viru
vaccin
live
attenu
cold
adapt
influenza
viru
administ
nasal
vaccin
flumist
contain
three
coldadapt
b
influenza
recombin
virus
contain
backbon
viru
grown
cold
incorpor
h
n
gene
differ
sourc
also
influenza
b
mean
shed
viru
day
longer
children
thu
herd
effect
case
ill
vaccin
usa
cdc
introduc
new
vaccin
year
quadrival
flu
vaccin
protect
two
influenza
virus
two
influenza
b
virus
standard
dose
quadrival
flu
vaccin
given
nasal
spray
approv
healthi
peopl
age
year
vaccin
chang
accord
predict
type
influenza
like
preval
particular
year
fda
chose
strain
influenza
one
strain
influenza
b
peopl
get
new
high
dose
inactiv
viru
vaccin
annual
strain
next
year
vaccin
chosen
februari
use
follow
season
vaccin
product
begin
strain
carri
drift
ha
na
gene
last
season
combin
refer
strain
grow
well
chick
egg
new
method
produc
vaccin
revers
genet
use
copi
gene
insert
plasmid
clone
back
refer
strain
influenza
develop
new
technolog
requir
produc
suffici
influenza
vaccin
alreadi
tri
variou
compani
includ
cellbas
rather
eggbas
live
attenu
inact
viral
vaccin
well
recombin
protein
vaccin
gene
ha
na
clone
baculoviru
vector
administ
purifi
protein
influenza
viru
gene
also
clone
viral
vector
vaccinia
viru
adenoviru
administ
either
replicationcompet
viru
defect
viru
fig
howev
creat
problem
discuss
chapter
gene
therapi
antibodi
may
inactiv
viru
develop
influenza
vaccin
extent
guess
game
sinc
one
predict
appear
novel
strain
viru
vaccin
fall
mani
categori
major
discuss
live
viru
vaccin
viru
attenu
either
multipl
passag
anim
multipl
passag
cell
cultur
passag
viru
undergo
mutat
particularli
rna
viru
high
rate
viru
emerg
often
attenu
possibl
ration
design
mutat
vitro
mutagenesi
influenza
vaccin
made
adapt
viru
grow
lower
temperatur
could
made
perform
reassort
laboratori
make
attenu
strain
although
recombin
laboratori
might
also
produc
virus
pathogen
anoth
approach
make
recombin
vaccin
use
viral
gene
produc
bacteria
yeast
baculoviru
system
vaccin
hepat
b
recombin
vaccin
produc
yeast
europ
second
vaccin
produc
chines
hamster
ovari
cell
vaccin
highli
immunogen
side
effect
largescal
studi
perform
atrisk
patient
antibodi
titer
high
goal
erad
recommend
univers
vaccin
program
taiwan
itali
mass
vaccin
infant
decreas
incid
hbv
infect
preval
chronic
carrier
also
incid
hepatocellular
carcinoma
yeast
insect
viru
baculoviru
also
use
produc
human
papilloma
viru
vaccin
two
vaccin
develop
highli
immunogen
gardasil
merck
co
quadrival
vaccin
hpv
type
cervarix
glaxo
smith
kline
biolog
hpv
type
vaccin
give
excel
protect
gardasil
also
demonstr
strong
protect
genit
wart
anal
cancer
controversi
surround
recommend
papilloma
vaccin
vaccin
recommend
girl
women
age
expos
hpv
vaccin
also
approv
men
boy
cdc
recommend
boy
young
fear
express
public
newspap
give
vaccin
teenag
encourag
promiscu
altern
propos
develop
vaccin
includ
use
purifi
protein
viral
protein
express
prokaryot
use
synthet
peptid
even
dna
protein
varieti
virus
clone
express
prokaryot
cell
cultur
proven
effect
mice
approv
appropri
regulatori
bodi
dna
vaccin
code
antigen
cancer
specif
bacterium
anthrax
deliv
plasmid
deliv
plasmid
harmless
strain
e
coli
major
problem
dna
vaccin
weak
antigen
respons
main
method
deliveri
intramuscular
inject
applic
skin
gene
gun
howev
larg
number
clinic
trial
dna
vaccin
way
one
day
may
possibl
eat
lettuc
vaccin
time
receiv
antibodi
bacteri
viru
infect
sound
like
scienc
fiction
yet
experiment
trial
produc
viral
antigen
way
research
laboratori
biotech
compani
introduc
anim
viral
gene
plant
genom
chloroplast
chloroplast
small
organel
prokaryot
origin
respons
photosynthesi
green
plant
analog
mitochondria
higher
organ
plantderiv
vaccin
biopharmaceut
cheap
produc
compar
cell
cultur
store
easi
scale
mass
product
safer
produc
sourc
sinc
less
likelihood
contamin
bacteria
even
virus
plant
system
much
econom
industri
system
produc
vaccin
would
ideal
third
world
countri
exampl
estim
produc
million
dose
influenza
vaccin
convent
pharmaceut
compani
sanofi
pennsylvania
would
cost
million
per
year
novarti
produc
million
dose
would
charg
billion
use
tobacco
plant
cost
would
million
per
year
produc
one
billion
dose
technolog
alreadi
avail
purif
necessari
product
although
ultim
aim
might
digest
vaccin
oral
vaccin
despit
fact
precaut
need
taken
vaccin
digest
stomach
enzym
obvious
appli
tobacco
plant
date
yield
product
experiment
system
tobacco
lettuc
grain
great
expect
howev
yield
greatli
enhanc
clone
desir
viral
gene
chloroplast
multipli
larg
number
plant
cell
thu
enrich
product
vaccin
produc
soybean
use
cauliflow
mosaic
viru
promot
antibodi
effect
prevent
infect
mous
model
indistinguish
monoclon
antibodi
produc
cell
cultur
whole
seri
monoclon
antibodi
produc
varieti
plant
use
plant
viru
vector
hepat
b
envelop
protein
produc
potato
lettuc
lupin
immunogen
digest
oral
norwalk
viru
capsid
protein
also
produc
potato
tobacco
plant
immunogen
protein
produc
resembl
empti
viral
capsid
tabl
far
amount
foreign
viral
protein
produc
plant
suffici
mass
vaccin
led
experiment
increas
yield
use
variou
promot
sequenc
ad
polyadenyl
site
mammalian
tissu
increas
yield
estim
yield
around
total
weight
make
practic
use
yield
increas
use
chloroplast
upto
copi
chloroplast
per
cell
result
accumul
total
protein
recombin
protein
desir
gene
incorpor
chloroplast
recombin
thu
clone
gene
surround
side
chloroplast
sequenc
method
transform
quit
differ
anim
cell
four
sixweekold
leav
select
transform
dna
coat
surfac
microparticl
gold
tungsten
shot
onto
leaf
surfac
great
forc
use
heliumdriven
particl
deliveri
devic
gene
gun
regener
leav
cut
small
leaf
disc
h
incub
dark
put
select
media
primari
shoot
gener
aris
within
week
initi
copi
plastid
genom
transform
leaf
cell
call
heteroplastom
homoplastomi
state
copi
chloroplast
genom
transform
achiev
perform
round
regener
select
put
transgen
shoot
character
transgen
integr
protein
express
hiv
gag
protein
dengu
viru
protein
produc
chloroplast
howev
product
yet
reach
human
clinic
trial
although
larg
invest
us
govern
agenc
may
take
year
see
clinic
trial
product
techniqu
patent
howev
may
way
futur
produc
cheap
vaccin
infecti
diseas
method
known
trade
molecular
farm
may
answer
vaccin
shortag
number
biotech
compani
pursu
cours
quot
announc
fraunhof
center
molecular
biotechnolog
http
regard
one
plant
plant
grow
tray
hydropon
cultur
miner
wool
oppos
soil
special
design
growth
modul
light
water
nutrient
precis
dose
distribut
special
develop
robot
bring
plant
station
station
carri
variou
insert
tini
seed
vacuum
infiltr
harvest
extract
plant
grow
four
week
vector
introduc
mean
vacuum
infiltr
process
goe
follow
robot
pick
tray
plant
turn
upsid
submerg
tobacco
plant
headfirst
water
water
hold
vector
biolog
carrier
contain
genet
inform
tell
plant
protein
produc
vacuum
appli
draw
air
water
plant
soon
switch
vacuum
plant
suck
water
togeth
vector
take
second
plant
put
back
growth
modul
grow
week
produc
protein
harvest
leav
cut
small
piec
homogen
fulli
autom
process
produc
liquid
protein
extract
end
product
clear
liquid
pilot
facil
capabl
produc
kg
biomass
month
roughli
correspond
million
unit
vaccin
futur
vaccin
product
